Bemiparin

Brand names: IVOR IVORAT

Therapeutic Indications

Bemiparin is indicated for:

Deep venous thrombosis

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Subcutaneous

at least one of

Extracorporeal circulation procedure

Hemodialysis procedure

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Subcutaneous

Prevention of deep vein thrombosis and additionally

Surgical procedure

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Subcutaneous

Contraindications

Active ingredient Bemiparin is contraindicated in the following cases:

No gender/age discrimination

at least one of

Hepatic failure stage IV

Abnormal pancreatic function

No gender/age discrimination

at least one of

Acute bacterial endocarditis

Subacute bacterial endocarditis

No gender/age discrimination

Bleeding

No gender/age discrimination

Regional anesthesia

No gender/age discrimination

Disseminated intravascular coagulation

No gender/age discrimination

at least one of

Operation on brain

Procedure on spinal cord

Surgical procedure on eye region

Operation on the ear

No gender/age discrimination

at least one of

High risk of bleeding

Peptic ulcer

Cerebral hemorrhage

Intracranial aneurysm

Intracranial tumour

No gender/age discrimination

Heparin-induced thrombocytopenia

< Previous: Overview

Next: Precautions >

Bemiparin

Therapeutic Indications

Treatment 1: Subcutaneous

Treatment 1: Subcutaneous

Treatment 1: Subcutaneous

Contraindications

Medication Recommendation

Related medicines